<DOC>
	<DOCNO>NCT01113333</DOCNO>
	<brief_summary>Primary Objective : - Assess safety tolerability single intra-articular dos SAR113945 patient knee osteoarthritis . Secondary Objective : - Assess systemic exposure SAR113945 follow intra-articular delivery .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics SAR113945 Following Intra-articular Administration Patients With Knee Osteoarthritis</brief_title>
	<detailed_description>The total study duration per subject range 4 20 week broken follow : - screening within 4 week dose , - follow-up 4 week ( 28 day ) single dose study medication , - prolong maximum 12 week plasma PK level &gt; Limit Of Quantification ( LOQ ) Day 28 .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Inclusion criterion : Male patient female patient non childbearing potential , age least 40 year primary knee osteoarthritis : Xray Magnetic Resonance Imaging ( MRI ) evidence Kellgren Lawrence Grades II./III joint space narrow osteophyte formation , Western Ontario MacMaster ( WOMAC ) score â‰¦ 72 , American College Rheumatology ( ACR ) Clinical Radiographic criterion osteoarthritis . Exclusion criterion : Any uncontrolled , chronic condition laboratory finding , opinion Principal Investigator , could potentially put patient increase risk . Secondary osteoarthritis . Moderate/severe renal impairment . Underlying hepatobiliary disease and/or elevate Alanine Aminotransferase ( ALT ) &gt; 3 Upper Limit Normal range . Intraarticular injection within 3 month . Presence local skin abnormality affect knee joint . Unable maintain least 2 week prior entry study paracetamol metamizole analgesic . Any Investigational Product within 3 month . Any patient unlikely comply requirement study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>